The largest database of trusted experimental protocols

Hitrap mabselect column

Manufactured by GE Healthcare
Sourced in United States

The HiTrap MabSelect column is a pre-packed affinity chromatography column designed for the purification of monoclonal antibodies (mAbs) and related proteins. The column contains Protein A ligand immobilized on a high-performance agarose matrix, which enables the selective capture and purification of mAbs from complex sample mixtures.

Automatically generated - may contain errors

5 protocols using hitrap mabselect column

1

Recombinant Antibody Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody (D25, MPE8 and AM14) heavy and light chains were ordered from GenScript and cloned into pcDNA3.1. Antibodies were expressed by transient co-transfection of both heavy and light chain plasmids in Expi293F cells using PEI (Polyscience). Cell supernatants were harvested after 7 days and passed over a HiTrap MabSelect column (GE Healthcare). Bound antibodies were washed with PBS and eluted with 100 mM glycine at pH 2.9 into 1/10th volume of 1 M Tris-HCl pH 8.0. Final purification of mAbs was performed by SEC on a Superdex 200 10/300 GL (GE Healthcare) using PBS as the mobile phase.
+ Open protocol
+ Expand
2

Bivalent antibodies production using Expi293 system

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Expi293 expression system (ThermoFisher) was used to produce bsAbs CD73xEpCAM-IgG2s, CD73xMock-IgG2s, and MockxEpCAM-IgG2s. Briefly, Expi293 cells were transfected with plasmid encoding the bsAb of choice and cultured on a shaker platform (125 rpm) at 37 °C, 8% CO2 for 7 d. Next, conditioned culture supernatant was harvested and cleared by centrifugation (4000× g for 30 min), after which bsAbs were purified using an HiTrap Mab-select column connected to an ÄKTA Start chromatography system (GE Healthcare Life Sciences, Chicago, IL, USA).
+ Open protocol
+ Expand
3

Recombinant Antibody-SpyTag Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nimotuzumab-SpyTag and anti-MBP-SpyTag were expressed using the Gibco™ Expi293™ Expression System (Life Technologies, catalog number A14635), according to the manufacturer's protocol. Briefly, 1 day before transfection, Expi293F cells were diluted to 2 × 10 6 cells/ml in Expi293 Expression Medium (Life Technologies). On the day of transfection, 30 μg of plasmid DNA (1:1 ratio) was complexed with 80 μL ExpiFectamine™ 293 reagent. The complexed DNA was then transferred to 7.5 × 10 7 cells (final cell density of 2.5 × 10 6 cells/ml). The next day, enhancers 1 and 2 were added to the media to bring the final volume up to 30 ml. Cells were cultured for 6-7 days. Cells were spun down, and supernatant was collected and filtered through a 0.45-μm-membrane filter (Minisart, Sartorius Stedim). Protein A binding buffer (Sodium Phosphate 20 mM, 0.15 M NaCl, pH 7.2) was added to the supernatant, and the antibody-SpyTag was purified by GE Healthcare AKTA FPLC system using HiTrap MabSelect column (GE healthcare). The antibody-SpyTag was eluted using IgG elution buffer (Fisher Scientific) and neutralized with Neutralization Buffer (1 M Tris-HCl pH 9.0). Antibody-SpyTag was dialyzed overnight with phosphate-buffered saline (PBS) and concentrated using a 30 K MWCO filter (Millipore). Fragments were filter sterilized and stored at -80 °C.
+ Open protocol
+ Expand
4

Recombinant Antibody Expression Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Linear DNA cassettes for Ig VH, Vκ, and Vλ segments were synthesized as GBIocks at Integrated DNA Technologies and cloned into pRS5α expressing full-length IgG1 heavy, kappa light, or lambda light chains where appropriate, by Gibson assembly (New England Biolabs, E5510S) according to the recommended protocol. Variable regions of Ig chains were sequence verified. Plasmid DNA for paired Ig heavy and light chains were co-transfected into Expi293F cells using the Expi293 Expression System according to the recommended protocol. Culture media were harvested three days post-transfection by centrifugation. mAbs were purified with HiTrap MabSelect Columns (GE Healthcare, 28–4082-53) by FPLC according to the recommended protocol. Purified mAbs were characterized by SDS-PAGE and SEC-HPLC.
+ Open protocol
+ Expand
5

Glycoprofiling of Purified Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glycoprofiling was performed as previously published (Grav et al., 2015 (link)). Exponentially growing cells were seeded at 1×106 cells/mL and supernatant was harvested after 4 days by centrifugation. Supernatant for all samples was filtered before further processing. Rituximab was purified using HiTrap MabSelect columns (GE Healthcare) according to the manufacturer’s instructions. EPO containing supernatants (175 mL) were buffer exchanged with 400 mL 20 mM TRIS-HCl pH 8.0 using a VivaFlow 50 30 kDa MWCO cross flow cassette (Sartorius). Samples were loaded onto a Mono Q 5/50 GL column (GE Healthcare) and EPO was eluted using a gradient increase to 20 mM TRIS-HCl pH 8.0, 300 mM NaCl over 30 column volumes. EPO containing fractions were pooled and analyzed by SDS PAGE. Concentrations of Rituximab and EPO were measured by Nanodrop (Thermo Scientific). N-glycans from purified proteins were released and fluorescently labeled with GlykoPrep Rapid N-Glycan kit (ProZyme Inc., Hayward, CA). Labeled N-glycans were analyzed by LC-MS on a Thermo Ultimate 3000 HPLC with fluorescence detector coupled on-line to a Thermo Velos Pro Iontrap MS. Glycan abundance was measured by integrating the areas under normalized fluorescence spectrum peaks with Xcalibur software (Thermo Fisher Scientific) giving the relative amount of the glycans.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!